Johnson & Johnson MedTech 2025 Progress Review: Advancing Robotics, Pulsed Field Ablation, and AI Integration
Johnson & Johnson
Medical Device R&D and Manufacturer
Heart Future
Since October 2023Tim SchmidAppointedJohnson & Johnson Medical Technologies(Johnson & Johnson MedTech, abbreviated as "Johnson & Johnson") has been serving as the Executive Vice President and Global Chairman for nearly two years.
During this period, the company has been continuously advancing in multiple tracks of medical technology, fromSurgical RobotToPulsed Field Ablation(PFA), covering multidisciplinary scenarios such as interventional therapy and digital surgery, focusing on capability building represented by artificial intelligence and robotics. The goal is to evolve towards a smarter, more interconnected, and personalized healthcare direction, encompassing diverse specialties from interventional procedures to digital surgeries.
2025Year10Month15-16Day, TimSchmidWill be held in Santa Clara, California, USADeviceTalks West ConferenceDeliver the opening keynote speech, introducing Johnson & Johnson's latest innovations and next steps.
This article reviewsCompletedJohnson & Johnson so far in2025Key dynamics of the year, including platform technology iteration, product compliance progress, industry collaboration, and organizational updates.
# Function Enhancement Approved for Robotic Bronchoscopy:Monarch Quest
2025Year3Month, Johnson & JohnsonAnnounce its Monarch Quest Technology Obtained in the United StatesFDA Approval for UseBronchoscopy in Robot-Assisted Surgery。
Monarch The platform is described asThe First Robotic-Assisted Bronchoscopy System to Enter the Market, which aims to access and visualize the airway in a minimally invasive manner, assisting clinicians in performing biopsies on suspicious lung nodules. This enables earlier and more definitive diagnosis in lung cancer cases and accelerates the patient's entry into the treatment pathway.
On this basis,Monarch Navigation technology has received a new round of upgrades: this version introduces navigation capabilities driven by artificial intelligence algorithms, and is integrated withGE HealthCare TheOEC 3D MobileCBCT The imaging system has established a verifiedOEC Open Interface. Sources pointed out,Monarch Quest TheAI Navigation utilizes the full-stackNvidia Accelerated Computing Platform. In terms of hardware and system integration, Johnson & Johnson mentioned that the platform continues the system's stable reachable range and precision, adopting“Mirror body in sheath (scope-in-sheath）”The unique design and continuous visualization features; at the software level, enhanced navigation is integrated with intraoperative three-dimensional imaging data to improve the accuracy of targeting lung nodules.
From the perspective of bronchoscopy intervention pathways, the aforementioned iterations focus on“Enter—Identification—Biopsy”Stability and visualization capabilities throughout the entire process: Minimally invasive entry into the airway, continuous field of view assurance,AI Navigation and Intraoperative3D Information integration, jointly serving the sampling and early diagnosis and treatment process of highly suspicious nodules. The source text does not exceed these key points, and this article is also described accordingly.
# Join hands with industry partners to establish“Polyphonic AI Fund for Surgery”: For the pre-, intra-, and post-operative phasesAIPlan
2025Year6Month, Johnson & JohnsonLaunch Polyphonic AI Fund for Surgery(Surgical MultivoiceAIFund), AI solutions for preoperative, intraoperative, and postoperative issues accelerate governance,Nvidia WithAmazon Web Services（AWS) and other companies have joined the initiative.. The fund is positioned to advance in surgical scenariosAI The initiative extends, aiming to redefine modern surgical practices and improve patient outcomes.
In terms of focus, the fund emphasizes“Balancing Acceleration with Responsible Governance”Data Concept, Focus on Proposals in Three Directions:AI Model Development, Data Engineering and Management, andAI Governance. The source also mentioned that the program builds on Johnson & Johnson's practical foundation in the surgical field, while leveragingNvidia TheAI Infrastructure &AWS 's cloud capabilities; and about a year ago withNvidia In surgical robotsAI Form a承接relationship for related cooperation.
In terms of industrial synergy, the sources present“Clinical—Algorithm—Computing Power—Cloud”The collaborative framework: On the one hand, surgical business experience serves as the problem set and scenario context; on the other hand,AI Infrastructure and cloud platforms provide computing power and engineering capabilities. The goal of the fund is to promote problem-solving across the entire chain—front, middle, and back—and set boundaries and standards at the data governance level.
# Varipulse PFA Platform AccessFDA Approval for Update of Perfusion Flow Rate
2025Year7Month, Johnson & Johnson in itsPFA New Compliance Progress Achieved in Business:Varipulse PlatformThe perfusion flow rate update obtainedFDA Approved, this update reflects a continuous improvement orientation based on real-world clinical practice, demonstrating the company's commitment to advancing.PFA The Commitment to Innovation.
Varipulse Platform for Atrial Fibrillation (AFib`) Treatment, will`PFA AndCarto 3 Mapping system combined; core devices include variable annular, multi-electrodeVaripulse Catheter (its annular structure is formed by laser-cut nitinol tubing),TruPulse Energy Generator withCarto 3 3D Cardiac Mapping System. Heart Future reviewed the platform in2024Year11Month ObtainedFDA Approval for use inAFib Treatment, Johnson & JohnsonCompared with already ownedPFA The approved companies are at the same regulatory node.2025At the beginning of the year, the company temporarily suspended operations across the United States.Varipulse All cases were reviewed due to four reported neurovascular events; sales activities resumed one month later.
# Appointment of Electrophysiology and Neurovascular Business Organization:Michael Bodner Appointed as Group Chairman
2025Year3Month,Michael Bodner Announced Appointment asChairman of the Company Group for Johnson & Johnson's Electrophysiology and Neurovascular Businesses。Not long after, the Global President of Johnson & Johnson NeurovascularMark Dickinson Announcement of Service in the Company26Plan to leave the job after the Chinese New Year and return to the UK.“In order to be closer to family and explore new opportunities”. Subsequently,Christian Cuzick Assume this position.
Heart Future Bodner A brief review of the resume: In the past two years, the focus has been on the company's cardiac recovery (Heart Recovery) and Circulatory Reconstruction (Circulation Restoration) Unit; this position began in2023Year, at that timeJasmina Brooks Appointed to Johnson & Johnson's Electrophysiology BusinessBiosense Webster The president. Prior to this,Bodner Lead the electrophysiology business while being responsible for integration.2022After the completion of the acquisition in the yearAbiomed。Bodner Indicates:“I am proud to return to my home inJ&J Team for Career Start——Help drive our rapidly growing cardiovascular product portfolio forward.”
This passage conveys changes in organizational structure and responsibilities: In the fields of electrophysiology and neurovascular, the new group chairman has taken office, bridging past management experience in circulatory support-related businesses while also aligning with the historical role of the electrophysiology business.
# Ottava Surgical Robot Completes First Batch of Cases: Key Milestone Entering Research Phase
2025Year4Month,Johnson & JohnsonReport its highly anticipated Ottava Robotic-Assisted Surgical PlatformAchieve New Milestone:Researchers have completed the first batch of cases. Source willOttava Positioned as a multi-specialty soft tissue surgical robot, it can support surgical needs across anatomical regions and multiple surgical specialties.
Ottava Key Timeline of the Robotic-Assisted Surgical Platform:
2020Year11Month: First disclosure by the company Ottava Relevant information; after that, it remained relatively low-key for quite a long time;
2021Year10Month: Affected by various factors, the R&D timeline has been postponed by approximately two years from the original plan;
2024Year10Month: The company announced to FDA Submit Clinical Trial Exemption (IDE); Less than a month later,FDA Approval ofIDE, makingJohnson & JohnsonAble to initiate relevant research;
2025Year4Month: Completion of the first batch of cases marks the research work entering the practical operation stage.
After the study was completed, Johnson & JohnsonPlan toFDA Submit the robotde novo Authorization application, targeting indications covering multiple general surgical procedures in the upper abdomen, including gastric bypass, sleeve gastrectomy, small bowel resection, and hiatal hernia repair, among others.
# AI Side by Side with Robots: From Platform Upgrade to Ecosystem Collaboration
In Monarch Quest In China,AI Navigation Algorithm and Mobility3DImaging Interface IntegrationListed as the core of this upgrade, andUnderlying dependency full-stackNvidia Accelerated Computing Platform；
InSurgical Ecosystem Synergy In, with Polyphonic AI Fund for Surgery As a hub,United Nvidia WithAWS Waiting for partners, focusing on model development and data engineering/Management andAI Governance: Modeling problems and allocating resources by treating the preoperative, intraoperative, and postoperative phases as a continuum.
In Ottava On the timeline, the sources collectively highlight key milestones in the R&D progress and research implementation, indicating that the robot platform is“Program Disclosure—R&D Rhythm Reevaluation—Clinical Research Initiation—First Case Completed—(Future)de novo Declaration”Linear path advancement;
In Varipulse The PFA In the track,Integration of Systems and Mapping PlatformsCharacteristics are prominent, and the update of perfusion parameters has been approved.“Temporary Suspension—Review—Recovery”The summary jointly constitutes2025Annual Regulatory and Clinical Operations Slice.
The above content shows“Platformization Capability + Ecological Collaboration”ParallelThe picture: on the one hand, the in-depth optimization of a single platform (such asMonarch Integration of Navigation and Imaging,Varipulse Parameter updates); on the other hand, cross-disciplinary collaboration throughout the entire surgical process (AI Fund collaborates with multiple technology companies), jointly targeting“Smarter and More Connected”The Practice Theme.
# Connection between Organization and Operations: Position Adjustment to Undertake the Cardiovascular Landscape
At the organizational level, the source disclosed the appointment of the group chairman for the electrophysiology and neurovascular businesses, as well as related executive personnel changes. In parallel with technological advancements, adjustments in talent and management structure are being made:
Michael Bodner The new appointment brings him back to the management of cardiovascular-related portfolios. His previous two-year experience in the cardiac recovery and circulation reconstruction unit, along with his earlier leadership in electrophysiology and efforts in advancing the integration of acquisition targets, are considered by sources as the foundation for his new role.
In the neurovascular business,Mark Dickinson Choose to step down after a long term of service, and by Christian Cuzick Assume the position. This transition provides organizational assurance for business continuity and the advancement of a new phase.
# Summary of Key Products and Platform Highlights
For the convenience of industry readers to quickly review, the key products appearing in the source are now listed below./Summary of Platform Features:
Monarch Robotic Bronchoscopy System (Monarch Quest Upgrade）
Objective: Minimally invasive access and visualization of the airway, assisting in biopsy of suspected pulmonary nodules;
Navigation Upgrade:AI Algorithm-driven, establish withGE HealthCare OEC 3D MobileCBCT 's empirically validated open interface;
Computing Platform: Full-stack Adoption Nvidia Accelerated Computing Platform;
Mechanical/System Features: Mirrored Body-in-Sheath Design, Continuous Visualization;
Data Fusion: Enhanced Navigation and Intraoperative 3D Imaging Integration for More Precise Nodule Targeting.
Polyphonic AI Fund for Surgery(SurgeryAIFund）
Collaborators: Including Nvidia、AWS Including the joint array;
Focus:AI Model Development, Data Engineering and Management,AI Governance;
Goal: Accelerated and Governance-Compliant Surgery AI Solution, Covering Preoperative/Intraoperative/Postoperative.
Varipulse PFA Platform (Biosense Webster）
Scenario: Atrial Fibrillation Treatment;
Composition: Variable Annular Multi-Electrode Varipulse Catheter (formed by laser cutting of nitinol tubing into rings),TruPulse Generator,Carto 3 3D Mapping System;
Regulatory Progress:2025Year7Monthly AcquisitionFDA Approval for the update of perfusion flow rate;2024Year11Monthly Platform AcquisitionFDA Approved for use inAFib；2025Sales in the U.S. were suspended earlier this year due to a review of four reported neurovascular events, and resumed a month later.
Tissue Appointment
Michael Bodner Appointed as Chairman of the Electrophysiology and Neurovascular Group; in the previous two years, focused on the Cardiac Recovery and Circulation Reconstruction Unit; earlier led electrophysiology and promoted the integration of acquisition targets;
Global President of Neurovascular Transition Christian Cuzick; PredecessorMark Dickinson Announce Departure.
Ottava Surgical Robot
Type: Multi-specialty Soft Tissue Robot;
Timeline:2020Year11Disclosed for the first time in the month;2021Year10Monthly R&D timeline postponed;2024Year10Monthly SubmissionIDE, which was subsequently approved and the research initiated;2025Year4Completed the first batch of cases in a month;
Planning: After the research is completed, it is proposed to FDA Submitde novo Authorization Application; Target indications cover multiple upper abdominal general surgeries (gastric bypass, sleeve gastrectomy, small bowel resection, hiatal hernia repair, etc.).
# Multidisciplinary Technical Pathway: Interconnected,Personalization and ProcessOptimization
Johnson & Johnson2025The annual progress reflects three integrated pathways:
Interconnection and Integration：Monarch Integrate navigation with intraoperative3DImaging is connected via an interface;Varipulse Integrate the energy platform with the three-dimensional mapping system;Ottava Then, on the timeline of research advancement, the platform capabilities will be gradually improved. The extension of connectivity...Polyphonic AI The fund further expands, and cross-enterprise collaboration incorporates computing power and cloud resources into the resolution of surgical problems.
Personalization and Intelligence：AI The parallel advancement of navigation, full-stack acceleration computing platforms, and data governance points to initiatives carried out based on scenario differences.“Intelligentization”Support. The source did not discuss the specific implementation paths at the individual level, but from the perspective of surgical procedures./The platform angle presents a perspective on“Faster, More Accurate, More Accessible”The诉求.
Process and Workflow Optimization：Platform upgrades generally emphasize intraoperative visualization, navigation accuracy, parameter optimization, and system coupling to reduce uncertainty and enhance stability and efficiency. Whether it is robotic attempts in bronchoscopy sampling, atrial fibrillation ablation, or upper abdominal general surgery procedures, the source information revolves around“Process Optimization”The theme unfolds.
# Conclusion
In summary, Johnson & Johnson in2025Year around robots,PFA WithAI Three Major Directions of the Ecosystem Progress Continuously:
InRobotDirection,Ottava Completion of the first batch of cases and clarification of the follow-up de novo Path Planning for Authorization Applications;
In PFA Direction,Varipulse Completed the regulatory node for perfusion flow rate updates while retaining summary-style information regarding operational adjustments at the beginning of the year and subsequent recovery.
InAISystem IntegrationDirection,Monarch Quest TheAINavigation and3DImaging interface, andPolyphonic AI Fund for Surgery The multi-party collaboration jointly outlines“From Platform to Ecosystem”The method of technological advancement;
Organization and PersonnelIn terms of electrophysiology and neurovascular management architecture, key appointments and transitions have been completed to support the continuity of technology and business.
GCC2025
Full Disease Solutions for Cardiovascular Devices
